Our top pick for
IMARA Inc is a biotechnology business based in the US. IMARA shares (IMRA) are listed on the NASDAQ and all prices are listed in US Dollars. IMARA employs 16 staff and has a market cap (total outstanding shares value) of USD$383.3 million.
|Latest market close||USD$23.73|
|52-week range||USD$13.4 - USD$62.71|
|50-day moving average||USD$23.2382|
|200-day moving average||USD$23.704|
|Wall St. target price||USD$41.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.4155|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||68.54%|
|1 month (2020-12-17)||-0.59%|
|3 months (2020-10-15)||21.57%|
|6 months (2020-07-15)||9.56%|
|1 year (2020-01-13)||N/A|
|2 years (2019-01-13)||N/A|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-13)||N/A|
|Gross profit TTM||USD$0|
|Return on assets TTM||-25.46%|
|Return on equity TTM||0%|
|Market capitalisation||USD$383.3 million|
TTM: trailing 12 months
There are currently 492,570 IMARA shares held short by investors – that's known as IMARA's "short interest". This figure is 5.6% up from 466,602 last month.
There are a few different ways that this level of interest in shorting IMARA shares can be evaluated.
IMARA's "short interest ratio" (SIR) is the quantity of IMARA shares currently shorted divided by the average quantity of IMARA shares traded daily (recently around 40242.647058824). IMARA's SIR currently stands at 12.24. In other words for every 100,000 IMARA shares traded daily on the market, roughly 12240 shares are currently held short.
However IMARA's short interest can also be evaluated against the total number of IMARA shares, or, against the total number of tradable IMARA shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IMARA's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 IMARA shares in existence, roughly 30 shares are currently held short) or 0.0614% of the tradable shares (for every 100,000 tradable IMARA shares, roughly 61 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against IMARA.
Find out more about how you can short IMARA stock.
We're not expecting IMARA to pay a dividend over the next 12 months.
Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.